Open AccessP1417: PROPHYLACTIC NAC PROMOTED HEMATOPOIETIC RECONSTITUTION BY IMPROVING ENDOTHELIAL CELLS AFTER HSCT: A PHASE 3, OPEN‐LABEL RANDOMIZED TRIAL
Author(s) -
Wang Y.,
Kong Y.,
Zhao H.Y.,
Zhang Y.Y.,
Wang Y.Z.,
Xu L.P.,
Zhang X.H.,
Liu K.Y.,
Huang X.J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848528.52063.24
Subject(s) - medicine , tolerability , cumulative incidence , clinical endpoint , gastroenterology , hematopoietic stem cell transplantation , adverse effect , acute leukemia , pancytopenia , leukemia , transplantation , randomized controlled trial , bone marrow , surgery